Foundation Medicine has a big IDEA—Improving Diagnostics Education and Awareness—and, now, it's handing out a new grant attached to the program. Specifically, the Boston-based precision medicine ...

NEW YORK--(BUSINESS WIRE)--Massive Bio, a cutting-edge AI driven clinical trial matching platform provider, and Foundation Medicine, Inc. today announced a strategic collaboration to increase patient ...

BOSTON & EL MONTE, Calif.--(BUSINESS WIRE)--Foundation Medicine, Inc., a genomics company committed to transforming cancer care, today announced plans to launch two new germline tests, ...

Foundation Medicine, Inc., a precision medicine company transforming lives in cancer care and beyond, today announced a partnership with Manifold, the leading artificial intelligence (AI) data ...

Findings Published in Nature Medicine Highlight Clinical Application of Next-Generation Sequencing to Suggest Targeted Therapeutic Options for Patients CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation ...

CAMBRIDGE, Mass. & BOSTON, January 12, 2026--(BUSINESS WIRE)--ConcertAI, a leading oncology real-world evidence data and AI SaaS technology company, and Foundation Medicine, a global, patient-focused ...

BOSTON and PRINCETON, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Foundation Medicine, Inc. and PMV Pharmaceuticals, Inc. (PMVP) (NASDAQ: PMVP; “PMV Pharma”) today announced a partnership to develop ...

First and only company with 100 approved and active companion diagnostic indications for next-generation sequencing in the United States and Japan, setting the standard for high-quality genomic ...

BOSTON--(BUSINESS WIRE)-- Foundation Medicine, Inc. today announced a collaboration with Syndax Pharmaceuticals (Nasdaq: SNDX) to develop a companion diagnostic for the identification of acute myeloid ...